ISSN 2979-8582 · Article No. 054
Dr. Onuoha-Ojeamiren Gloria Olomiekido: Department of Medical Microbiology Ambrose Alli University AAU Ekpoma , Nigeria
Dr. Onuoha Augunus Chidubem: Department of Chemical Pathology, Ambrose Alli University, Ekpoma
Iduda Ojeamiren: Department of Laboratory Sciences, Dartford and Gravesham NHS Trust, Kent
Ajay kumar P: Department of Laboratory Medicine, Central Hospital, South Westen Railway, Hubli,Karnataka, India
Professor Samuel Olowo Sunday: Department of Medical Microbiology, Ambrose Alli University, Ekpoma
Enteric fever, primarily caused by Salmonella enterica serovar Typhi, remains a major global public health challenge. Accurate and rapid diagnosis is critical for effective patient management and the prevention of complications. While blood culture is the diagnostic gold standard, its utility is limited by low sensitivity, long turnaround times, and resource constraints in endemic areas. Serological assays detecting Typhoid IgG and IgM antibodies offer a rapid, accessible alternative. IgM antibodies appear early in the acute phase of infection, serving as a primary marker for active or recent disease. Conversely, IgG antibodies rise later, persisting for months to provide insights into past exposure, chronic carriage, or secondary immune responses. This article reviews the clinical application, diagnostic relevance, limitations, and operational utility of Typhoid IgG/IgM testing in contemporary enteric fever management.
Keywords
This article is published under the Creative Commons Attribution 4.0 International License . Free to read, share, and adapt with attribution.
British Journal of Contemporary Research
Open Access · Peer Reviewed · Published by Bexford Publishing Ltd
Browse All Issues